Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urinary Tract Calculi III: Medical Management

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Urinary Tract Calculi V: Nursing Management

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD).

Annals of the rheumatic diseases·2026

Same author

Analysis of central corneal thickness in systemic lupus erythematosus.

Frontiers in medicine·2025

Same author

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.

Arthritis research & therapy·2025

Same author

Association between central corneal thickness and systemic lupus erythematosus: a cross-sectional study protocol.

Frontiers in medicine·2024

Same author

Systemic inflammation in asymptomatic hyperuricaemia with sonographic crystal deposits, including a comparison with normouricaemia and gout.

Rheumatology (Oxford, England)·2024

Same author

Corrigendum: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum.

Frontiers in medicine·2024

Search research articles

Related Experiment Videos

Therapeutic advances in gout.

Eliseo Pascual¹, Francisca Sivera

¹Rheumatology Section, Hospital General Universitario de Alicante, Alicante, Spain. pascual_eli@gva.es

Current Opinion in Rheumatology

|February 7, 2007

Summary

Recent gout management advances include new guidelines and medications like febuxostat. Effective treatment requires accurate diagnosis, crystal elimination, and lifestyle changes for better patient outcomes.

Area of Science:

Rheumatology
Internal Medicine

Background:

Gout diagnosis and management standards are currently suboptimal.
Published guidelines from EULAR offer a framework for improved care.
Gout is increasingly associated with metabolic syndrome and cardiovascular events.

Purpose of the Study:

To review recent advancements in gout management.
To highlight new therapeutic options and diagnostic criteria.

Main Methods:

Literature review of recent publications on gout management.
Analysis of new guidelines, medications, and outcome measures.

Main Results:

New guidelines and quality indicators for gout care are available.
Allopurinol remains primary for lowering serum uric acid, but febuxostat shows promise for insufficient responses.

Related Experiment Videos

New cyclooxygenase 2 inhibitors, like etoricoxib, are effective for gouty inflammation.

Lifestyle and dietary modifications are crucial due to gout's links with metabolic syndrome and myocardial infarction.

Conclusions:

Effective gout management necessitates improved physician attitudes and accurate diagnosis via urate crystal identification.
Treatment aims should focus on crystal elimination from joints and tissues.
Optimal use of available therapies, including lifestyle changes, is essential for successful gout control.